| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 307.82B | 335.69B | 304.74B | 276.81B | 260.50B | 237.38B |
| Gross Profit | 140.09B | 155.20B | 137.07B | 122.69B | 111.80B | 99.18B |
| EBITDA | 40.17B | 47.28B | 37.58B | 30.97B | 24.34B | 21.61B |
| Net Income | 16.18B | 21.98B | 13.32B | 10.05B | 5.03B | 6.42B |
Balance Sheet | ||||||
| Total Assets | 367.24B | 383.88B | 369.24B | 376.26B | 355.92B | 327.53B |
| Cash, Cash Equivalents and Short-Term Investments | 37.96B | 43.49B | 39.43B | 32.68B | 36.32B | 30.74B |
| Total Debt | 110.68B | 104.87B | 118.25B | 127.13B | 138.21B | 120.73B |
| Total Liabilities | 209.39B | 206.37B | 211.22B | 224.92B | 224.16B | 205.90B |
| Stockholders Equity | 155.64B | 175.78B | 155.97B | 149.10B | 129.79B | 120.07B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 27.09B | 22.25B | 21.70B | -2.92B | 11.56B |
| Operating Cash Flow | 0.00 | 36.77B | 32.61B | 32.73B | 9.26B | 20.36B |
| Investing Cash Flow | 0.00 | -14.79B | -9.12B | -15.10B | -15.54B | -9.32B |
| Financing Cash Flow | 0.00 | -20.45B | -16.52B | -23.02B | 10.56B | -13.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥417.85B | 10.79 | 8.36% | 2.71% | 2.88% | 213.02% | |
74 Outperform | ¥598.34B | 19.38 | 9.36% | 3.61% | 9.44% | 30.20% | |
73 Outperform | ¥643.83B | 29.30 | ― | 1.46% | 10.15% | 64.88% | |
72 Outperform | ¥147.61B | 17.56 | ― | 2.93% | 3.63% | 35.38% | |
68 Neutral | ¥595.40B | 26.19 | ― | 3.52% | 14.43% | 114.59% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
52 Neutral | ¥673.00B | -8.27 | 1.29% | 2.88% | -5.33% | -1578.42% |